Skip to content

PDA

Also called Pentadeca Arginate / BPC-157 arginate salt

The BPC-157 pentadecapeptide supplied as an arginate salt rather than the usual acetate.

  • TypePeptide
  • FormInjectable
  • Researched forHealing & Recovery

Where to get PDA

Ion Peptide
Injectable
Code CAMERON

The only form sold. Research compound, not approved for human use.

Shop injectable at Ion Peptide

The short version

  • Why people research itTendon, gut and soft-tissue repair — the BPC-157 peptide as an arginate salt, sold on shelf stability rather than a different mechanism.
  • What the evidence isNo human trial of PDA exists, and none of BPC-157 either.
  • What to watchA new lump or a mole that changes.

How PDA works

Start with what an arginate salt is, because that is the only thing distinguishing this page from the BPC-157 page, and the answer is smaller than the marketing suggests. A peptide with free carboxyl groups can be isolated as a salt with any suitable counter-ion.

So what CAN a counter-ion change? Three real things, all physical. The hygroscopicity and shelf stability of the lyophilized powder; and the solubility profile.

The sequence, and therefore the mechanism, is the same: VEGFR2 and nitric-oxide signaling driving angiogenesis, with the growth-factor upregulation behind the tendon, gut, muscle and nerve repair BPC-157 is known for. What the arginate counter-ion changes is the physical chemistry of the salt, and vendors market it as the more stable of the two. That is a formulation claim, not a potency claim: nobody has published a head-to-head of arginate against acetate in a living system.

  • Injectable

On the goal map: Angiogenesis & cytoprotection (Heal an injury)

Research on PDA6 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Evidence on file: Same peptide as BPC-157 - strong animal, heavy anecdotal, limited human. The arginate salt specifically has no comparative data at all.

Human clinical evidence

  • No human trial of PDA exists, and none of BPC-157 either. PDA is the same pentadecapeptide supplied as an arginate salt, so it inherits BPC-157's evidence position exactly: strong animal work, no completed randomized human efficacy trial, and a 2023 FDA move to bulk-substances category 2 that restricts compounding — a judgement about missing data, not a finding of harm.

    No completed human trial
  • Nothing compares the two salts in a living system. The arginate is marketed as more stable. It is not a claim about what happens after injection, and no published work bridges the two.

Correlative data

  • The anecdotal record people cite for PDA is BPC-157's record, because the peptide is the same. That record is large and it is also the clearest case in the Vault of anecdote being a weak instrument: soft-tissue injuries and gut flares resolve on their own, so anything taken during recovery collects the credit.

  • PDA's own anecdotal history is short — it entered the research market recently, and reports specific to the arginate salt are too few and too new to separate from BPC-157's.

How the mechanism reads

  • Identical to BPC-157 by definition: VEGFR2 and nitric-oxide signaling driving angiogenesis, with growth-factor upregulation behind tendon, gut, muscle and nerve repair. A counter-ion changes the salt's physical chemistry, not the peptide's sequence or its receptor interactions.

    Mechanistic
  • The mechanistic argument FOR the arginate is pharmacokinetic — a more stable salt could mean more intact peptide surviving to the point of action. Plausible, unmeasured, and worth treating as a hypothesis rather than a feature.

    Mechanistic

Sources

  • He L, et al. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Frontiers in Pharmacology 2022 · PMID 36588717
  • Sikiric P, et al. Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future. Gut and Liver 2020 · PMID 31158953
  • Sikiric P, et al. Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome. World Journal of Gastroenterology 2022 · PMID 35125818
  • Sikiric P, et al. Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis Function. Pharmaceuticals (Basel) 2023 · PMID 37242459
  • Perovic D, et al. Novel Therapeutic Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration of Pentadecapeptide BPC 157 Therapy. Current Issues in Molecular Biology 2022 · PMID 35678659

PDA safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Cancer history or a suspected tumor: pro-angiogenic VEGFR2 signaling can feed vessel growth to tumors.
  • Proliferative eye disease such as diabetic retinopathy: VEGF-type signaling worsens abnormal vessel growth.
  • Pregnancy: angiogenesis signaling has no safety data in gestation.
  • Anticoagulant use: nitric-oxide effects on vessels and platelets could add to bleeding tendency.

What’s expected

  • Less perceived joint, tendon or gut irritation over weeks, as the repair pathway is nudged.
  • Mild dizziness or a warm feeling from nitric-oxide signaling.
  • Little felt change, since evidence is mostly animal.
  • No comparative data exist for the arginate salt itself.

Watch for

  • A new lump or a mole that changes.
  • Blurred vision or floaters.
  • Fainting or a sharp drop in blood pressure.
  • Redness, warmth or pus where it is applied.

Labs that tell you it’s working

  • hs-CRP (C-Reactive Protein, High Sensitivity)
  • ESR (Sed Rate, Westergren)
  • Complete Blood Count (CBC) w/ Differential
  • Comprehensive Metabolic Panel (CMP)

PDA is the BPC-157 sequence as an arginate salt, so VEGFR2 and nitric-oxide angiogenesis applies; the salt itself has no comparative data. PMID 20388964

Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON

PDA FAQ4 common questions

Is PDA approved for human use?
No. PDA is a research compound. No completed randomized human trial has given it yet.
What is PDA researched for?
Tendon, gut and soft-tissue repair — the BPC-157 peptide as an arginate salt, sold on shelf stability rather than a different mechanism.
Which labs show whether it's doing anything?
hs-CRP; ESR; Complete Blood Count; Comprehensive Metabolic Panel: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for PDA: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what PDA is. Skool covers how it is run.

Free on this page

What PDA is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What PDA is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool